Drug · DIN 02468530
BOSENTAN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 14, 2026.
- Drug Identification Number (DIN)
- 02468530
- Company (DIN owner)
- Panda Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bosentan C02KX01
- Class
- Human
- Record last updated
- July 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BOSENTAN (BOSENTAN MONOHYDRATE) | 125 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 22, 2017: NOC 19841Abbreviated New Drug Submission (ANDS)
Other DINs named BOSENTAN
- DIN 02463555 · Cancelled Pre Market
- DIN 02463563 · Cancelled Pre Market
- DIN 02468522 · Cancelled Pre Market